仟源医药：9月22日召开董事会会议

Company Overview - QianYuan Pharmaceutical (SZ 300254) announced on September 22 that its fifth board meeting was held via telecommunication to review the proposal for bank credit borrowing [1] - As of the report date, QianYuan Pharmaceutical has a market capitalization of 2.6 billion yuan [1] Revenue Composition - For the year 2024, the revenue composition of QianYuan Pharmaceutical is as follows: - Pharmaceutical manufacturing accounts for 96.68% - DNA gene preservation and prenatal environment testing services account for 1.93% - Health food accounts for 0.79% - Other businesses account for 0.51% - Commercial activities account for 0.1% [1]